Default object view. Click to create a custom template, Node ID: 179608, Object ID: 107389

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA...

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

No relation

Yes

No relation

No

22/02/2017 3:27 pm

No